Kymera Therapeutics

Kymera Therapeutics is a clinical-stage biotechnology company dedicated to reimagining the treatment of human disease. Their innovative approach utilizes targeted protein degradation (TPD), a disease-agnostic modality that leverages the body's natural protein disposal system to selectively target and eliminate disease-causing proteins. This revolutionary technology opens up possibilities for treating a wide range of conditions, addressing previously “undruggable” targets.

Driven by a passionate team of biopharmaceutical leaders and a culture that prioritizes collaboration, innovation, and patient impact, Kymera has established a robust pipeline of first-in-class therapeutic candidates. Their mission to revolutionize healthcare is evident in their commitment to developing high-value programs poised to change patients' lives, advancing a new generation of medicines with a profound impact on the future of disease treatment.

Kymera Therapeutics offers a number of flexible work arrangements to support employees' well-being and work-life balance. These include three office shutdowns throughout the year, summer schedules, and generous paid time off, providing employees with the flexibility to step away from work when needed. The company also encourages social interaction and community engagement through various activities like book clubs and pickleball, ensuring employees have opportunities to relax and recharge.

Kymera Therapeutics provides a comprehensive benefits package designed to support employees and their families' emotional and financial wellbeing. The company offers competitive programs that allow employees to integrate work, family, and community in a healthy and meaningful way. These programs include paid time off, office shutdowns, summer schedules, and philanthropic opportunities. Kymera also provides resources for employees to relax and recharge, invest in themselves, and learn and grow.

Kymera Therapeutics is a clinical-stage biotechnology company dedicated to reinventing the treatment of human disease. Their mission is to build a global medicines company that harnesses novel modalities, like targeted protein degradation, to revolutionize healthcare. They are committed to advancing these cutting-edge technologies to address previously undrugged disease-causing proteins, challenging conventional treatment paradigms and delivering a new generation of medicines in a disease-agnostic manner.

Kymera Therapeutics fosters a collaborative and inclusive culture that values innovation, transparency, and a deep commitment to improving patients' lives. They encourage their employees, known as "Kymerians," to be pioneers, embracing challenges with courage and resilience. The company promotes an environment where diverse perspectives are welcomed, and teamwork is celebrated, creating a dynamic workplace that allows employees to learn, grow, and contribute their best work.

Kymera Therapeutics is committed to fostering a diverse and inclusive workplace, where all employees feel valued, seen, and heard. They believe that a diverse team with a range of perspectives leads to better decision-making and innovation, ultimately benefiting patients. Their efforts include actively recruiting and retaining a diverse workforce, promoting a culture of inclusivity, and partnering with patient advocacy groups to better understand the needs of diverse communities. Kymera also emphasizes the importance of leadership diversity, with nearly half of their management team and board of directors being women.